Daniel Ortiz1, Arshad Jahangir1, Maharaj Singh1, Suhail Allaqaband1, Tanvir K Bajwa1, Mark W Mewissen2. 1. From the Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health, Madison (D.O., M.S., S.A., T.K.B.); Center for Integrative Research on Cardiovascular Aging, Aurora University of Wisconsin Medical Group, Milwaukee (A.J.); and Vascular Center at Aurora St Luke's Medical Center, Milwaukee, WI (M.W.M.). 2. From the Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health, Madison (D.O., M.S., S.A., T.K.B.); Center for Integrative Research on Cardiovascular Aging, Aurora University of Wisconsin Medical Group, Milwaukee (A.J.); and Vascular Center at Aurora St Luke's Medical Center, Milwaukee, WI (M.W.M.). publishing11@aurora.org.
Abstract
BACKGROUND: Access site hematomas and pseudoaneurysms are the most frequent complications of peripheral vascular intervention (PVI); however, their incidence and risk factors remain unclear. METHODS AND RESULTS: We retrospectively analyzed data from the multicenter Vascular Quality Initiative on 22 226 patients who underwent 27 048 PVI from August 2007 to May 2013. Primary end points included incidence and predictors of access site complications (ASCs), length of postprocedural hospitalization, discharge status, and 30-day and 1-year mortality. ASC complicated 936 procedures (3.5%). Of these, 74.4% were minor complications, 9.7% were moderate requiring transfusion, 5.4% were moderate requiring thrombin injection, and 10.5% were severe requiring surgery. Predictors of ASC were age >75 years, female sex, white race, no prior PVI, nonfemoral arterial access site, >6-Fr sheath size, thrombolytics, arterial dissection, fluoroscopy time >30 minutes, nonuse of vascular closure device, bedridden preoperative ambulatory status, and urgent indication. Mean hospitalization was longer after procedures complicated by ASC (1.2±1.6 versus 1.9±1.9 days; range, 0-7 days; P=0.002). Severity of ASC correlated with higher rates of discharge to rehabilitation/nursing facilities compared with home discharge. Patients with severe ASC had higher 30-day mortality (6.1% versus 1.4%; P<0.001), and those with moderate ASC requiring transfusion had elevated 1-year mortality (12.1% versus 5.7%; P<0.001). CONCLUSIONS: Several factors independently predict ASC after PVI. Appropriate use of antithrombotic therapies and vascular closure device in patients at increased risk of ASC may improve post-PVI outcomes.
BACKGROUND: Access site hematomas and pseudoaneurysms are the most frequent complications of peripheral vascular intervention (PVI); however, their incidence and risk factors remain unclear. METHODS AND RESULTS: We retrospectively analyzed data from the multicenter Vascular Quality Initiative on 22 226 patients who underwent 27 048 PVI from August 2007 to May 2013. Primary end points included incidence and predictors of access site complications (ASCs), length of postprocedural hospitalization, discharge status, and 30-day and 1-year mortality. ASC complicated 936 procedures (3.5%). Of these, 74.4% were minor complications, 9.7% were moderate requiring transfusion, 5.4% were moderate requiring thrombin injection, and 10.5% were severe requiring surgery. Predictors of ASC were age >75 years, female sex, white race, no prior PVI, nonfemoral arterial access site, >6-Fr sheath size, thrombolytics, arterial dissection, fluoroscopy time >30 minutes, nonuse of vascular closure device, bedridden preoperative ambulatory status, and urgent indication. Mean hospitalization was longer after procedures complicated by ASC (1.2±1.6 versus 1.9±1.9 days; range, 0-7 days; P=0.002). Severity of ASC correlated with higher rates of discharge to rehabilitation/nursing facilities compared with home discharge. Patients with severe ASC had higher 30-day mortality (6.1% versus 1.4%; P<0.001), and those with moderate ASC requiring transfusion had elevated 1-year mortality (12.1% versus 5.7%; P<0.001). CONCLUSIONS: Several factors independently predict ASC after PVI. Appropriate use of antithrombotic therapies and vascular closure device in patients at increased risk of ASC may improve post-PVI outcomes.
Authors: Linda M Sulzbach-Hoke; Sarah J Ratcliffe; Stephen E Kimmel; Daniel M Kolansky; Rosemary Polomano Journal: J Cardiovasc Nurs Date: 2010 May-Jun Impact factor: 2.083
Authors: Timothy A Sanborn; Ramin Ebrahimi; Steven V Manoukian; Brent T McLaurin; David A Cox; Frederick Feit; Martial Hamon; Roxana Mehran; Gregg W Stone Journal: Circ Cardiovasc Interv Date: 2010-01-26 Impact factor: 6.546
Authors: Cédric Delhaye; Kohei Wakabayashi; Gabriel Maluenda; Loic Belle; Itsik Ben-Dor; Manuel A Gonzalez; Michael A Gaglia; Rebecca Torguson; Zhenyi Xue; William O Suddath; Lowell F Satler; Kenneth M Kent; Joseph Lindsay; Augusto D Pichard; Ron Waksman Journal: Am Heart J Date: 2010-06 Impact factor: 4.749
Authors: Steven P Marso; Amit P Amin; John A House; Kevin F Kennedy; John A Spertus; Sunil V Rao; David J Cohen; John C Messenger; John S Rumsfeld Journal: JAMA Date: 2010-06-02 Impact factor: 56.272
Authors: Christos Kasapis; Hitinder S Gurm; Stanley J Chetcuti; Khan Munir; Ann Luciano; Dean Smith; Herbert D Aronow; Elias H Kassab; Michael F Knox; Mauro Moscucci; David Share; P Michael Grossman Journal: Circ Cardiovasc Interv Date: 2010-11-09 Impact factor: 6.546
Authors: Shmuel Fuchs; Ran Kornowski; Igal Teplitsky; David Brosh; Eli Lev; Hana Vaknin-Assa; Itsik Ben-Dor; Zaza Iakobishvili; Eldad Rechavia; Alexander Battler; Abed Assali Journal: Cardiovasc Revasc Med Date: 2009 Apr-Jun
Authors: Sameer K Mehta; Andrew D Frutkin; Jason B Lindsey; John A House; John A Spertus; Sunil V Rao; Fang-Shu Ou; Matthew T Roe; Eric D Peterson; Steven P Marso Journal: Circ Cardiovasc Interv Date: 2009-05-08 Impact factor: 6.546
Authors: Bhaskar Bhardwaj; John A Spertus; Kevin F Kennedy; W Schuyler Jones; David Safley; Thomas T Tsai; Herbert D Aronow; Amit N Vora; Yashashwi Pokharel; Arun Kumar; Robert R Attaran; Dmitriy N Feldman; Ehrin Armstrong; Anand Prasad; Bruce Gray; Adam C Salisbury Journal: JACC Cardiovasc Interv Date: 2019-06-24 Impact factor: 11.195
Authors: Joseph Anderson; Ryan King; Thomas Brothers; Jacob Robison; Ravi Veeraswamy; Mathew Wooster; Rupak Mukherjee; Jean Marie Ruddy Journal: Ann Vasc Surg Date: 2020-01-07 Impact factor: 1.466
Authors: Ramya C Mosarla; Ehrin Armstrong; Yonatan Bitton-Faiwiszewski; Peter A Schneider; Eric A Secemsky Journal: J Soc Cardiovasc Angiogr Interv Date: 2022-08-20
Authors: Lars Jakobsen; Niels R Holm; Michael Maeng; Troels Thim; Steen D Kristensen; Lone H Mogensen; Evald H Christiansen Journal: BMC Cardiovasc Disord Date: 2022-02-23 Impact factor: 2.298